2023-509807-34-00
CTIS ↗
ACU193-201
Early Alzheimer’s Disease (Mild Cognitive Impairment and Mild Dementia Due to Alzheimer’s Disease)
biotech · Alzheimer Disease · ABOS
Acumen Pharmaceuticals
Acumen Pharmaceuticals trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.
Boston, USA HQ
66 Employees
Public company Type
ABOS · NYSE Ticker
Company details
- Status
- Public
- HQ
- Boston, USA
- Employees
- 66
- Programs
- 4
- Drugs
- 9
- Patents
- 6
Acumen Pharmaceuticals clinical trials
Registry index of 4 ClinicalTrials.gov studies linked to Acumen Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.
Acumen Pharmaceuticals trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Acumen Pharmaceuticals.